Clinical TrialID 5214
A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
NCT00152191
Breast Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5214
- Evidence Id
- 5214
- Core Evidence Id
- 5214
- Source Clinical Trial Id
- 5196
- Herb2 Clinical Trial Id
- HBCT005196
- Nct Id
- NCT00152191
- Title
- A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Breast Cancer
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: UFT (uracil, tegafur)|DRUG: cyclophosphamide, methotrexate, and fluorouracil
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- Female
- Age
- Adult, Older_Adult
- Enrollment
- 1300
- Outcome Measure
- Relapse-free survival, every course for first three courses, then every other course
- Sponsor Collaborator
- Taiho Pharmaceutical Co., Ltd.
- Funded By
- INDUSTRY
- Location
- National Cancer Center, 5-1-1, Tsukiji, chuo-ku, Tokyo, Japan
- Other Id
- 1023001
- Start Date
- 1996-10
- Primary Completion Date
- 2007-10
- Completion Date
- 2008-01
- First Posted
- 2005-09-09
- Results First Posted
- Last Update Posted
- 2011-07-07
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00152191
- Title Cn
- Title En
- A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
- Bilingual Status
- semi_complete